← Back to all trials
Recruiting
NCT05682807
Effect of Caffeine Versus Probiotic on Preterm Neonates With Bronchopulmonary Dysplasia
Conditions: Bronchopulmonary Dysplasia
Sex: All
Ages: 0 Weeks – 37 Weeks
Phase: PHASE3
Enrollment: 90
Sponsor: Tanta University
Location: Egypt
Summary
The aim of this study is to evaluate the effectiveness of caffeine versus probiotics supplementation as adjuvant therapy for preterm neonates with Bronchopulmonary dysplasia (BPD).
Eligibility Criteria
Inclusion Criteria:Male and female preterm neonates less than 37 weeks gestational age.Suffering from Bronchopulmonary dysplasia (BPD) diagnosed as follow:History: Preterm infant with persistence oxygen dependency up to 28 days of life.Clinical signs: increase work of breathing, increase oxygen requirements , increase in apnea , bradycardia and retraction.Laboratory: arterial blood gases and electrolytes.Radiology: streaky interstitial markings, patchy atelectasis , intermingled with cystic areas and severe lung hyperinflation.Exclusion Criteria:Term and post term neonatesNeonates with congenital infectionsNeonates with major congenital anomalies
Source: ClinicalTrials.gov (NCT05682807). StuddyBuddy aggregates publicly available trial information.
